Oneness Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	1,694	1,048	812.83	5,655	332.96	217.64
Short-Term Investments	4,194	5,971	6,960	2,392	7,473	8,099
Cash & Short-Term Investments	5,888	7,019	7,773	8,047	7,806	8,317
Cash Growth	-17.85%	-9.70%	-3.40%	3.08%	-6.14%	423.69%
Accounts Receivable	31.94	18.34	25.77	13.08	14.59	444.45
Other Receivables	92.52	77.88	50.77	19.86	114.2	70.37
Receivables	124.46	96.22	76.54	32.95	128.79	514.82
Inventory	110.78	115.16	122.74	111.4	81.32	50.19
Other Current Assets	92.9	62.83	45.93	42.2	35.31	55.31
Total Current Assets	6,216	7,293	8,018	8,233	8,051	8,937
Property, Plant & Equipment	1,030	1,106	1,195	1,033	1,038	1,046
Long-Term Investments	3,151	3,737	4,096	3,920	3,871	2,585
Goodwill	57.44	57.44	89.14	89.14	89.14	89.14
Other Intangible Assets	982.23	1,125	1,682	2,010	2,388	2,474
Long-Term Accounts Receivable	12.41	-	-	-	32.41	32.94
Long-Term Deferred Tax Assets	194.12	137.57	79.21	97.46	62.85	38.67
Other Long-Term Assets	195.61	204.05	204.05	197.65	197.86	180.73
Total Assets	11,839	13,660	15,364	15,580	15,731	15,384
Accounts Payable	1.62	2.73	1.7	1.52	2.5	48.43
Accrued Expenses	95.29	103.57	119.05	155.39	78.16	58.6
Current Portion of Leases	45.11	41.18	34.25	13.25	12.73	23.23
Current Income Taxes Payable	-	0.12	0.12	12.69	35.1	-
Other Current Liabilities	25.78	35.32	60.24	25.76	28.75	23.44
Total Current Liabilities	167.8	182.92	215.36	208.6	157.24	153.69
Long-Term Leases	343.61	365.18	397.95	250.09	270.34	279.86
Long-Term Unearned Revenue	169.25	170.68	176.07	145.99	1,155	1,155
Long-Term Deferred Tax Liabilities	191.26	140.41	76.56	95.22	58.18	35.09
Other Long-Term Liabilities	0.47	0.47	0.48	0.48	0.48	0.48
Total Liabilities	872.39	859.65	866.43	700.38	1,642	1,625
Common Stock	4,795	4,791	4,545	3,910	3,853	3,771
Additional Paid-In Capital	6,494	7,623	9,050	8,637	9,469	9,157
Retained Earnings	-1,004	-1,154	-1,267	359.98	-1,036	-633.57
Treasury Stock	-25.78	-25.78	-25.78	-25.78	-47.38	-75.81
Comprehensive Income & Other	229.93	1,066	1,750	1,737	1,778	1,415
Total Common Equity	10,489	12,299	14,053	14,618	14,016	13,633
Minority Interest	477.01	501.02	444.07	262.28	72.95	126.38
Shareholders' Equity	10,966	12,800	14,497	14,880	14,089	13,760
Total Liabilities & Equity	11,839	13,660	15,364	15,580	15,731	15,384
Total Debt	388.72	406.35	432.2	263.34	283.07	303.09
Net Cash (Debt)	5,499	6,613	7,341	7,783	7,523	8,014
Net Cash Growth	-18.60%	-9.92%	-5.69%	3.46%	-6.13%	536.11%
Net Cash Per Share	11.48	13.83	15.50	16.50	16.52	18.80
Filing Date Shares Outstanding	478.42	478.03	476.23	466.02	458.4	447.43
Total Common Shares Outstanding	478.42	478.03	476.23	466.02	458.4	447.43
Working Capital	6,048	7,110	7,803	8,025	7,894	8,784
Book Value Per Share	21.92	25.73	29.51	31.37	30.58	30.47
Tangible Book Value	9,450	11,117	12,282	12,519	11,539	11,070
Tangible Book Value Per Share	19.75	23.26	25.79	26.86	25.17	24.74
Buildings	640.6	640.27	637.35	602.54	580.99	510.38
Machinery	557.08	554.04	547.55	522.99	456.01	399.52
Construction In Progress	12.03	1.98	18.24	-	13.03	48.15
Leasehold Improvements	63.11	58.15	27.56	14.56	14.01	9.16

Source: S&P Global Market Intelligence. Standard template. Financial Sources.